1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Prevalence of Communicable & Non-communicable Diseases
4.2.2 Technological Advancements in Molecular Diagnostics
4.2.3. Increasing Investments and Fundings to Improve Healthcare Systems in Middle East & Africa
4.2.4. Rising Healthcare Expenditure
4.3. Restraints
4.3.1. Inconsistencies in Medical Device Regulations Across Middle East & African Countries
4.3.2. High Costs of Molecular Diagnostic Tests
4.4. Opportunities
4.4.1. Emerging Medical and Wellness Tourism in the UAE
4.4.2. Increasing Focus on Companion Diagnostics
4.5. Challenges
4.5.1. Shortage of Skilled Professionals
4.6. Industry & Technology Trends
4.7. Regulatory Scenario
4.8. Porter’s Five Forces Analysis
4.9. Adjacent/Related Market Analysis
5. Middle East & Africa Molecular Diagnostics Market Assessment—by Offering
5.1. Overview
5.2. Kits & Reagents
5.3. Instruments
5.4. Software & Services
6. Middle East & Africa Molecular Diagnostics Market Assessment—by Test Type
6.1. Overview
6.2. Laboratory Tests
6.3. Point-of-Care (POC) Tests
7. Middle East & Africa Molecular Diagnostics Market Assessment—by Technology
7.1. Overview
7.2. Polymerase Chain Reaction (PCR)
7.3. In Situ Hybridization (ISH)
7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5. Microarrays
7.6. Sequencing
7.7. Mass Spectrometry
7.8. Other Technologies
8. Middle East & Africa Molecular Diagnostics Market Assessment—by Application
8.1. Overview
8.2. Infectious Diseases
8.2.1. Respiratory Diseases
8.2.2. Hepatitis
8.2.3. HIV
8.2.4. Chlamydia Trachomatis/Neisseria Gonorrhoeae
8.2.5. Human Papillomavirus (HPV)
8.2.6. Healthcare-Associated Infections (HAIs)
8.2.7. Other Infectious Diseases
8.3. Oncology
8.3.1. Breast Cancer
8.3.2. Colorectal Cancer
8.3.3. Lung Cancer
8.3.4. Prostate Cancer
8.3.5. Lymphoma
8.3.6. Leukemia
8.3.7. Cervical Cancer
8.3.8. Other Cancer Types
8.4. Respiratory Diseases
8.5. Genetic Testing
8.6. Neurological Diseases
8.7. Cardiovascular Diseases
8.8. Other Applications
9. Middle East & Africa Molecular Diagnostics Market Assessment—by End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Academic & Research Institutes
9.5. Other End Users
10. Middle East & Africa Molecular Diagnostics Market Assessment—by Geography
10.1. Overview
10.2. Saudi Arabia
10.3. UAE
10.4. Oman
10.5. Kuwait
10.6. Egypt
10.7. South Africa
10.8. Rest of the Middle East & Africa
11. Competitive Analysis
11.1. Overview
11.2. Competitive Benchmarking
11.3. Competitive Dashboard
11.3.1 Market Leaders
11.3.2 Market Differentiators
11.3.3. Vanguards
11.3.4. Emerging Companies
11.4. Market Share Analysis/Market Ranking, by Key Players (2023)
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
12.1. AstraGene LLC
12.2. F. Hoffmann-La Roche Ltd.
12.3. Thermo Fisher Scientific Inc.
12.4. Becton, Dickinson and Company (U.S.)
12.5. Illumina, Inc.
12.6. AstraZeneca Gulf FZ LLC
12.7. QIAGEN N.V.
12.8. Danaher Corporation
12.9. Abbott Laboratories
12.10. Agilent Technologies, Inc.
(Note: SWOT is Provided for the Top 5 Players)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Middle East & Africa Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 2 Middle East & Africa Molecular Diagnostics Kits & Reagents Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Middle East & Africa Molecular Diagnostics Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Middle East & Africa Molecular Diagnostics Software & Services Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Middle East & Africa Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 6 Middle East & Africa Molecular Diagnostics Market for Laboratory Tests, by Country/Region, 2022–2031 (USD Million)
Table 7 Middle East & Africa Molecular Diagnostics Market for PoC Tests, by Country/Region, 2022–2031 (USD Million)
Table 8 Middle East & Africa Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 9 Middle East & Africa Molecular Diagnostics Market for Polymerase Chain Reaction (PCR), by Country/Region, 2022–2031 (USD Million)
Table 10 Middle East & Africa Molecular Diagnostics Market for In Situ Hybridization (ISH), by Country/Region, 2022–2031 (USD Million)
Table 11 Middle East & Africa Molecular Diagnostics Market for Isothermal Nucleic Acid Amplification Technology (INAAT), by Country/Region, 2022–2031 (USD Million)
Table 12 Middle East & Africa Molecular Diagnostics Market for Microarrays, by Country/Region, 2022–2031 (USD Million)
Table 13 Middle East & Africa Molecular Diagnostics Market for Mass Spectrometry, by Country/Region, 2022–2031 (USD Million)
Table 14 Middle East & Africa Molecular Diagnostics Market for Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 15 Middle East & Africa Molecular Diagnostics Market for Other Technologies Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Middle East & Africa Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 17 Middle East & Africa Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 18 Middle East & Africa Molecular Diagnostics Market for Infectious Diseases Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Middle East & Africa Molecular Diagnostics Market for Respiratory Diseases, by Country/Region, 2022–2031 (USD Million)
Table 20 Middle East & Africa Molecular Diagnostics Market for Hepatitis Testing, by Country/Region, 2022–2031 (USD Million)
Table 21 Middle East & Africa Molecular Diagnostics Market for HIV Testing, by Country/Region, 2022–2031 (USD Million)
Table 22 Middle East & Africa Molecular Diagnostics Market for CT/NG Testing, by Country/Region, 2022–2031 (USD Million)
Table 23 Middle East & Africa Molecular Diagnostics Market for Human papillomavirus (HPV) Testing, by Country/Region, 2022–2031 (USD Million)
Table 24 Middle East & Africa Molecular Diagnostics Market for Healthcare-associated Infections (HAIs) Testing, by Country/Region, 2022–2031 (USD Million)
Table 25 Middle East & Africa Molecular Diagnostics Market for Other Infectious Diseases Testing, by Country/Region, 2022–2031 (USD Million)
Table 26 Middle East & Africa Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 27 Middle East & Africa Molecular Diagnostics Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 28 Middle East & Africa Molecular Diagnostics Market for Breast Cancer, by Country/Region, 2022–2031 (USD Million)
Table 29 Middle East & Africa Molecular Diagnostics Market for Colorectal Cancer, by Country/Region, 2022–2031 (USD Million)
Table 30 Middle East & Africa Molecular Diagnostics Market for Lung Cancer, by Country/Region, 2022–2031 (USD Million)
Table 31 Middle East & Africa Molecular Diagnostics Market for Prostate Cancer, by Country/Region, 2022–2031 (USD Million)
Table 32 Middle East & Africa Molecular Diagnostics Market for Lymphoma, by Country/Region, 2022–2031 (USD Million)
Table 33 Middle East & Africa Molecular Diagnostics Market for Leukemia, by Country/Region, 2022–2031 (USD Million)
Table 34 Middle East & Africa Molecular Diagnostics Market for Cervical Cancer, by Country/Region, 2022–2031 (USD Million)
Table 35 Middle East & Africa Molecular Diagnostics Market for Other Cancer Types, by Country/Region, 2022–2031 (USD Million)
Table 36 Middle East & Africa Molecular Diagnostics Market for Genetic Testing, by Country/Region, 2022–2031 (USD Million)
Table 37 Middle East & Africa Molecular Diagnostics Market for Neurological Diseases, by Country/Region, 2022–2031 (USD Million)
Table 38 Middle East & Africa Molecular Diagnostics Market for Cardiovascular Diseases, by Country/Region, 2022–2031 (USD Million)
Table 39 Middle East & Africa Molecular Diagnostics Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 40 Middle East & Africa Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 41 Middle East & Africa Molecular Diagnostics Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 42 Middle East & Africa Molecular Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 43 Middle East & Africa Molecular Diagnostics Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 44 Middle East & Africa Molecular Diagnostics Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 45 Middle East & Africa Molecular Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 46 Saudi Arabia: Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 47 Saudi Arabia: Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 48 Saudi Arabia: Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 49 Saudi Arabia: Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 50 Saudi Arabia: Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 51 Saudi Arabia: Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 52 Saudi Arabia: Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 53 UAE: Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 54 UAE: Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 55 UAE: Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 56 UAE: Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 57 UAE: Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 58 UAE: Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 59 UAE: Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 60 Oman: Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 61 Oman: Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 62 Oman: Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 63 Oman: Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 64 Oman: Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 65 Oman: Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 66 Oman: Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 67 Kuwait: Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 68 Kuwait: Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 69 Kuwait: Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 70 Kuwait: Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 71 Kuwait: Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 72 Kuwait: Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 73 Kuwait: Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 74 Egypt: Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 75 Egypt: Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 76 Egypt: Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 77 Egypt: Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 78 Egypt: Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 79 Egypt: Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 80 Egypt: Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 81 South Africa: Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 82 South Africa: Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 83 South Africa: Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 84 South Africa: Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 85 South Africa: Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 86 South Africa: Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 87 South Africa: Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 88 Rest of Middle East & Africa: Molecular Diagnostics Market, by Offering, 2022–2031 (USD Million)
Table 89 Rest of Middle East & Africa: Molecular Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 90 Rest of Middle East & Africa: Molecular Diagnostics Market, by Technology, 2022–2031 (USD Million)
Table 91 Rest of Middle East & Africa: Molecular Diagnostics Market, by Application, 2022–2031 (USD Million)
Table 92 Rest of Middle East & Africa: Molecular Diagnostics Market for Infectious Diseases, by Type, 2022–2031 (USD Million)
Table 93 Rest of Middle East & Africa: Molecular Diagnostics Market for Oncology, by Type, 2022–2031 (USD Million)
Table 94 Rest of Middle East & Africa: Molecular Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 95 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for the Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Middle East & Africa Molecular Diagnostics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 8 Middle East & Africa Molecular Diagnostics Market, by Test Type, 2024 Vs. 2031 (USD Million)
Figure 9 Middle East & Africa Molecular Diagnostics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 10 Middle East & Africa Molecular Diagnostics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 11 Middle East & Africa Molecular Diagnostics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 12 Middle East & Africa Molecular Diagnostics Market, by Country/Region
Figure 13 Market Dynamics: Middle East & Africa Molecular Diagnostics Market
Figure 14 Middle East & Africa Molecular Diagnostics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 15 Middle East & Africa Molecular Diagnostics Market, by Test Type, 2024 Vs. 2031 (USD Million)
Figure 16 Middle East & Africa Molecular Diagnostics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 17 Middle East & Africa Molecular Diagnostics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 18 Middle East & Africa Molecular Diagnostics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 19 Middle East & Africa Molecular Diagnostics Market, by Country/Region, 2024 Vs. 2031 (USD Million)
Figure 20 Middle East & Africa Molecular Diagnostics Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players (2020–2024)
Figure 22 Middle East & Africa Molecular Diagnostics Market: Competitive Benchmarking, by Type
Figure 23 Middle East & Africa Molecular Diagnostics Market: Competitive Dashboard
Figure 24 Middle East & Africa Molecular Diagnostics Market: Market Share Analysis/ Market Ranking (2023)
Figure 25 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)
Figure 26 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 27 Becton, Dickinson and Company: Financial Overview (2022)
Figure 28 Illumina, Inc.: Financial Overview (2022)
Figure 29 AstraZeneca Gulf FZ LLC: Financial Overview (2022)
Figure 30 QIAGEN N.V.: Financial Overview (2022)
Figure 31 Danaher Corporation: Financial Overview (2022)
Figure 32 Abbott Laboratories: Financial Overview (2022)
Figure 33 Agilent Technologies, Inc.: Financial Overview (2023)